回到主页

SeekIn Receives CE Mark Approval for SeekInCare® Pan Cancer Early Detection Test

This First-of-its-Kind Blood-based Pan Cancer Early Detection Test Combines Protein Markers, Genomic and Epigenetic Features of Cancer in Blood

SHENZHEN, China, Feb. 24, 2022 /PRNewswire/ -- SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, today announced the CE (Conformité Européenne) Mark for SeekInCare® Cancer Detection Kit and is now ready to launch this test in European markets.

 

所有文章
×

还剩一步!

确认邮件已发至你的邮箱。 请点击邮件中的确认链接,完成订阅。

好的